Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcriptional regulatory protein XylR is a bacterial transcription factor that plays a critical role in the regulation of catabolic pathways for aromatic hydrocarbons and sugars. In Pseudomonas putida, XylR is the master regulator of the TOL plasmid, where it activates the degradation of toluene and xylenes by binding to upstream activating sequences and interacting with the sigma-54-dependent RNA polymerase [1, 9]. In other species such as Escherichia coli and Bacillus subtilis, XylR primarily regulates xylose metabolism, acting as a repressor or activator in response to D-xylose levels [6, 8]. Recent studies in Mycobacteria have identified XylR as a global regulator of lipid metabolism, affecting cell wall composition, biofilm formation, and antibiotic resistance [7, 11]. This regulatory role makes XylR a potential therapeutic target for the development of novel antimicrobials against Mycobacterium tuberculosis and other pathogens, as its inhibition or modulation can impair bacterial survival in the host [10, 18]. Furthermore, XylR is extensively used in synthetic biology as a molecular switch or biosensor for environmental monitoring and controlled gene expression [4, 30].
XylR acts as a transcriptional regulator that binds to specific DNA sequences (operators or upstream activating sequences) to either repress or activate the expression of genes involved in catabolic pathways. Upon binding its ligand (e.g., toluene or xylose), it undergoes a conformational change that alters its DNA-binding affinity or its ability to interact with RNA polymerase (often sigma-54 dependent), thereby modulating gene expression [1, 3, 9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcriptional regulatory protein XylR (XylR).